Shengli Xia

机构：Henan Provincial Center for Disease Control and Prevention

发表论文 70 篇 · 总被引 5120 次 · h-index 26

代表论文

• Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial (2020 · The Lancet Infectious Diseases · 被引 1210)
• Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults (2021 · JAMA · 被引 837)
• Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes (2020 · JAMA · 被引 807)
• Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial (2021 · The Lancet Infectious Diseases · 被引 202)
• Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial (2020 · Vaccine · 被引 37)
• Efficacy, safety and immunogenicity of live attenuated varicella vaccine in healthy children in China: double-blind, randomized, placebo-controlled clinical trial (2019 · Clinical Microbiology and Infection · 被引 34)